So, how good is AI modeling at predicting tick distribution?

One of the best explanations for increased tick activity and geographical range is the phenomenon of rising temperatures, which has led to milder winters and a more suitable habitat for ticks. Therefore, many attempted to model and predict the presence of ticks on the European continent using various sophisticated mathematical models.

Researchers from various European research institutions attempted to use modeling approaches to assess the ability of different climate niches to explain the known distribution of I. ricinus and D. reticulatus in Europe*. The study concluded that climate is not the only factor deciding tick distribution. Other factors than climate itself, such as habitat type, host availability and anthropogenic impacts, could contribute to determining tick presence or absence at the local or regional scale.

Another study attempted to project the habitat suitability for the three tick species under current and future climatic conditions based on the ecological niche modeling approach**. According to the modeling results, three tick species Ixodes ricinus, Dermacentor reticulatus, and D. marginatus, will benefit from the projected climate changes in Europe.

The modeling shows that the habitat suitability for Ixodes ricinus, Dermacentor reticulatus, and Dermacentor marginatus tends to increase in Europe under future climatic conditions, with projected area expansions towards Eastern Europe.

We need to be ready for ticks and tick-borne diseases.

Access to the library of parasites and vector-borne diseases

View Supporting Resources →

REFERENCES:

*Noll M, Wall R, Makepeace BL, Newbury H, Adaszek L, Bødker R, Estrada-Peña A, Guillot J, da Fonseca IP, Probst J, Overgaauw P, Strube C, Zakham F, Zanet S, Rose Vineer H: Predicting the distribution of Ixodes ricinus and Dermacentor reticulatus in Europe: a comparison of climate niche modelling approaches. Parasites & Vectors 2023, 16:384.

**Cunze S, Glock G, Kochmann J, Klimpel S: Ticks on the move-climate change-induced range shifts of three tick species in Europe: current and future habitat suitability for Ixodes ricinus in comparison with Dermacentor reticulatus and Dermacentor marginatus. Parasitol Res 2022, 121:2241-52.

A LEADING LINE OF DEFENSE AGAINST FLEAS AND TICKS

No matter how you choose to dose your pets, BRAVECTO® delivers long-lasting, systemic parasite protection, for effective & confident control.

Dog

Chew

icon-demodex

Fast, Easy, Lasting Protection. An oral dose offering 12-Week flea and tick protection* in a single chew dogs love.1

Injectable

With just one dose you can deliver continuous, uninterrupted flea and tick protection for one full year.2,3,4

SPOT-ON

icon-demodex

For owners who prefer spot-ons without giving up the 12-Week flea and tick protection. For dogs on special diets, at risk for gastrointestinal sensivity, or are at risk of picky eaters.5

Cat

SPOT-ON WITH BROAD-SPECTRUM

Spot on cats packshot UK latest

An even broader range of parasite protection for cats in one convenient and lasting dose applied on the skin.6

SPOT-ON

Convenient, proven safety profile, and lasting flea and tick protection for cats in one tube applied on the skin.7

REFERENCES:

  1. BRAVECTO CHEW DATASHEET: https://www.noahcompendium.co.uk/?id=-454352&fromsearch=true#iosfirsthighlight
  2. Fisara, P. and F. Guerino, Year-round efficacy of a single treatment of fluralaner injectable suspension (BRAVECTO Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs. Parasites & Vectors, 2023. 16(1): p. 378.
  3. Fisara, P. and F. Guerino, Year-round efficacy of a single treatment of fluralaner injectable suspension (BRAVECTO Quantum™) against repeated infestations with Ixodes holocyclus in dogs. Parasites & Vectors, 2023. 16(1): p. 375.
  4. BRAVECTO® INJECTABLE. (BRAVECTO® 150 mg/ml power and solvent for suspension for injection for dogs) DATASHEET: https://www.noahcompendium.co.uk/?id=-485823&fromsearch=true#iosfirsthighlight
  5. BRAVECTO DOG SPOT ON DATASHEET: https://www.noahcompendium.co.uk/?id=-461528&fromsearch=true#iosfirsthighlight
  6. BRAVECTO PLUS SPOT ON DATASHEET: https://www.noahcompendium.co.uk/?id=-469893&fromsearch=true#iosfirsthighlight
  7. BRAVECTO CAT SPOT ON DATASHEET: https://www.noahcompendium.co.uk/?id=-481108&fromsearch=true#iosfirsthighlight

*BRAVECTO® has a 12-week duration of efficacy against flea and tick species indicated on the SPCs, except for BRAVECTO® Chewable Tablets which also include an 8-week immediate and persistent killing activity against Rhipicephalus sanguineus.

Bravecto® Spot-on for Cats and Bravecto® Chewable Tablets, Spot-on for Dogs and Bravecto® 150 mg/ml powder and solvent for suspension for injection for dogs contain fluralaner. POM-V.
Bravecto® Plus Spot-on for Cats contains fluralaner and moxidectin. POM-V.
Further information is available from the SPC, Datasheet or package leaflet.

Advice should be sought from the medicine prescriber. Prescription decisions are for the person issuing the prescription alone. 

Use Medicines Responsibly.

MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.